BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 25356031)

  • 1. Gastrointestinal dysfunction in liver cirrhosis.
    Kalaitzakis E
    World J Gastroenterol; 2014 Oct; 20(40):14686-95. PubMed ID: 25356031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis.
    Kalaitzakis E; Sadik R; Holst JJ; Ohman L; Björnsson E
    Clin Gastroenterol Hepatol; 2009 Mar; 7(3):346-52. PubMed ID: 19200458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decompensated cirrhotics have slower intestinal transit times as compared with compensated cirrhotics and healthy controls.
    Chander Roland B; Garcia-Tsao G; Ciarleglio MM; Deng Y; Sheth A
    J Clin Gastroenterol; 2013; 47(10):888-93. PubMed ID: 23632359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of gastric sensorimotor dysfunction in gastrointestinal symptoms and energy intake in liver cirrhosis.
    Kalaitzakis E; Simrén M; Abrahamsson H; Björnsson E
    Scand J Gastroenterol; 2007 Feb; 42(2):237-46. PubMed ID: 17327944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathogenesis of gastrointestinal bacterial overgrowth.
    Husebye E
    Chemotherapy; 2005; 51 Suppl 1():1-22. PubMed ID: 15855746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options.
    Konturek PC; Brzozowski T; Konturek SJ
    J Physiol Pharmacol; 2011 Dec; 62(6):591-9. PubMed ID: 22314561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased intestinal permeability in malnourished patients with liver cirrhosis.
    Norman K; Pirlich M; Schulzke JD; Smoliner C; Lochs H; Valentini L; Bühner S
    Eur J Clin Nutr; 2012 Oct; 66(10):1116-9. PubMed ID: 22872031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis.
    Sánchez E; Casafont F; Guerra A; de Benito I; Pons-Romero F
    Rev Esp Enferm Dig; 2005 Nov; 97(11):805-14. PubMed ID: 16438624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth.
    Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ
    J Clin Gastroenterol; 2015 Aug; 49(7):571-6. PubMed ID: 25319735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastrointestinal tract in liver disease: which organ is sick?
    Norman K; Pirlich M
    Curr Opin Clin Nutr Metab Care; 2008 Sep; 11(5):613-9. PubMed ID: 18685458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal dysfunction in liver cirrhosis: Its role in spontaneous bacterial peritonitis.
    Ramachandran A; Balasubramanian KA
    J Gastroenterol Hepatol; 2001 Jun; 16(6):607-12. PubMed ID: 11422611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal epithelial barrier function in liver cirrhosis: an extensive review of the literature.
    Pijls KE; Jonkers DM; Elamin EE; Masclee AA; Koek GH
    Liver Int; 2013 Nov; 33(10):1457-69. PubMed ID: 23879434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications.
    Bellot P; Francés R; Such J
    Liver Int; 2013 Jan; 33(1):31-9. PubMed ID: 23121656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut microbiota-related complications in cirrhosis.
    Gómez-Hurtado I; Such J; Sanz Y; Francés R
    World J Gastroenterol; 2014 Nov; 20(42):15624-31. PubMed ID: 25400446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acupuncture and regulation of gastrointestinal function.
    Li H; He T; Xu Q; Li Z; Liu Y; Li F; Yang BF; Liu CZ
    World J Gastroenterol; 2015 Jul; 21(27):8304-13. PubMed ID: 26217082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life.
    Kalaitzakis E; Simrén M; Olsson R; Henfridsson P; Hugosson I; Bengtsson M; Björnsson E
    Scand J Gastroenterol; 2006 Dec; 41(12):1464-72. PubMed ID: 17101578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small intestinal manometry.
    Hansen MB
    Physiol Res; 2002; 51(6):541-56. PubMed ID: 12613464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Patients with liver cirrhosis: mouth-cecum transit time and gastric emptying of solid foods].
    Chesta J; Lillo R; Defilippi C; Jouanee E; Massone MA; Maulén M; Zavala A
    Rev Med Chil; 1991 Nov; 119(11):1248-53. PubMed ID: 9723075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food and symptom generation in functional gastrointestinal disorders: physiological aspects.
    Farré R; Tack J
    Am J Gastroenterol; 2013 May; 108(5):698-706. PubMed ID: 23458851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension.
    Gunnarsdottir SA; Sadik R; Shev S; Simrén M; Sjövall H; Stotzer PO; Abrahamsson H; Olsson R; Björnsson ES
    Am J Gastroenterol; 2003 Jun; 98(6):1362-70. PubMed ID: 12818282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.